• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种新型抗心绞痛制剂:5-单硝酸异山梨酯]

[A new antianginal preparation: isosorbide-5-mononitrate].

作者信息

Martsevich S Iu, Metelitsa V I, Slastnikova I D, Simkhaev L S, Egorov L V, Blagodatskikh S V

出版信息

Kardiologiia. 1990 Oct;30(10):44-6.

PMID:2290270
Abstract

Repeated treadmill exercise tests were used in 20 patients with stable exercise-induced angina in order to comparatively examine various dosage forms of isosorbide-5-mononitrate (IMN) and isosorbide dinitrate (ID) during their single administration. The antianginal effect of conventional IMN tablets (Monisid, Bulgaria) lasted about 5 hours and 1-2 hours longer than that shown by long-acting tablets (Olicard, FRG) and lasted on an average of 12 hours. There was a correlation between the antianginal effect of IMN and its blood concentration. A significant individual variability was observed in the potency of all the dosage forms of IMN and ID under study. The dosage form of IMN had antianginal effects that were similar and even superior to those exhibited by ID.

摘要

对20例稳定型运动诱发心绞痛患者进行重复的跑步机运动试验,以便在单次给药期间比较5-单硝酸异山梨酯(IMN)和硝酸异山梨酯(ID)的各种剂型。传统IMN片剂(Monisid,保加利亚)的抗心绞痛作用持续约5小时,比长效片剂(Olicard,联邦德国)长1 - 2小时,平均持续12小时。IMN的抗心绞痛作用与其血药浓度之间存在相关性。在所研究的IMN和ID的所有剂型的效力方面观察到显著的个体差异。IMN的剂型具有与ID相似甚至优于ID的抗心绞痛作用。

相似文献

1
[A new antianginal preparation: isosorbide-5-mononitrate].[一种新型抗心绞痛制剂:5-单硝酸异山梨酯]
Kardiologiia. 1990 Oct;30(10):44-6.
2
[The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].[劳力型心绞痛患者服用常规剂型和长效剂型药物后5-单硝酸异山梨酯浓度与其抗心绞痛作用的关系]
Eksp Klin Farmakol. 1995 May-Jun;58(3):25-7.
3
[Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].[稳定型劳力性心绞痛患者硝酸盐类治疗的选择:普通硝酸异山梨酯与长效5-单硝酸异山梨酯制剂对比研究结果]
Kardiologiia. 2005;45(11):42-5.
4
Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.控释单硝酸异山梨酯治疗心绞痛:与标准剂型硝酸异山梨酯的比较
Can J Cardiol. 1991 Apr;7(3):125-30.
5
Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.5-单硝酸异山梨酯控释制剂与传统硝酸异山梨酯对稳定型心绞痛男性运动能力影响的比较。
Am J Cardiol. 1990 Jun 1;65(20):1308-12. doi: 10.1016/0002-9149(90)91318-z.
6
Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.单硝酸异山梨酯:稳定性心绞痛缓释制剂(依姆多)综述
Drugs. 1999 Feb;57(2):261-77. doi: 10.2165/00003495-199957020-00016.
7
Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
J Clin Pharmacol. 1991 Jul;31(7):636-40. doi: 10.1002/j.1552-4604.1991.tb03749.x.
8
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.单硝酸异山梨酯缓释片治疗稳定型劳力性心绞痛的疗效与安全性。
Am J Cardiol. 1993 Dec 1;72(17):1249-56. doi: 10.1016/0002-9149(93)90292-k.
9
Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Drugs. 1987;33 Suppl 4:104-10. doi: 10.2165/00003495-198700334-00019.
10
Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.缓释单硝酸异山梨酯(50毫克):用于心绞痛长期治疗的每日一次剂型的优化
Am J Cardiol. 1988 Mar 25;61(9):12E-14E. doi: 10.1016/0002-9149(88)90082-3.